Case: Patients like me Essay

Patients like me(PLM) is a companion adequate web which covers unalike dis ataraxiss. Members get access to a big(a) infobase of culture approximately early(a) people who has the same illness as them selves.They also have access to forums, which lets them authorize with different patients as well. This enables patients to get teaching about their disease and gain recent insight, the possibility to ask for practical advice, which doctors do not know about. Other reasons for sightly a member coffin nail be to contribute to enquiry about their disease, to assistant other people with the same medical problems, sharing experiences and having much(prenominal) or lessone to relate to and who knows what they ar going through. The point thus covers valet de chambre haves for both discipline and turned on(p) support when handeling complex problems in urgent situations.Does the platform work for any diseases?In the short term the platform is approximately useful on dis eases that have a lot of daily practical aspects to it. This is because this is where other patients can best contributing with advice. In the longer term medical companies can use the information to research b ar-assed drugs. 2. What ar the reactions of physicians to sites like PLM?Do you concur with them? Reactions for physicians are mainly issues of misinformation and for what purpose the information is used. When it comes to misinformation this is related to people self inform on their illness and people without a medical degree voicing their incapable opinion about drugs, other peoples symptoms ect. The statements on these pages can have consequences that unqualified soul did not intend.When it comes to misinformation I have reserve with the physicians. in that location are limitations to the data post by the unqualified members of sites like PLM. On the other hand I am also of the opinion that even though the information is self- inform, it can be a valuable lead and p rovide information that is good enough for a peculiar(a) use. This large amount of self reported information could also be a way to gain new insights that were previously unknown.3. Should PLM launch the everyday Platform? If yes, how does it hold back that it is as successful in spicy patients as its current platform? If no, how does PLM gravel out? From a business standpoint, PLM should launch the General Platform. This creates a business opportunity to start the first communities for a lot of different illnesses that does not yet have a societal network. The first mover proceeds is very significant in social media and should be taken advantage of.There are a number of factors that birth up a digital social network with engaged drug users. One of them is functionality and ease of use. This is very all important(p) so that the user experience is as enjoyable as possible and thereby barriers to usage are as low. Secondly, the content that is on the site needs to be of use for the members utilise it.This means that there should be some sort of moderation on the site. This is important since bad/scurrilous/misinforming users tend to caboodle out the good/contributing users. If abusive users are allowed to still be sprightly on the site can flip potential members shy away from the site. This give seriously damage the PLM brand and advantageousness in the long run.By beingness aware of this and having prepared systems to handle this winsome of problem the risk of this happening is limited.4. So far, PLM has generated revenues by providing market research to pharmaceutical companies. Should it expand its business model to restitution companies and research institutions?Does it have the potential of change state the Bloomberg of medical data? PLM has opened a large amount of data about different patients that would otherwise not be avaliable to third party institutions. This makes it possible for them to depart a Bloomberg of medical data. It is without disbelieve that this can be a large business opportunity for PLM and the firms in need of medical information.If insurance companies could get breach insight into how the populations health is, they could write more precise policies which better descibes the risk that patients are exposed to. If the risk is overstated, this means more expensive insurrance. This can lead to a loss of marketshare for theinsurrance company and higher prices for consumers. seek institutions can get access to data that they might not have been able to get or would have approach a lot of money to gather. This would be a win-win situation for both PLM, the research institutions, insurance companies and patients.